FDA warns Cordis over Cypher stents; may delay approval of catheter
This article was originally published in Clinica
Executive Summary
Johnson & Johnson’s cardiovascular unit Cordis could face further disruption to the supply of its Cypher stent following an FDA warning letter concerning violations found at the Puerto Rico facility that manufactures the devices.